TY - JOUR
T1 - Diagnosis and management of Cornelia de Lange syndrome
T2 - first international consensus statement
AU - Kline, Antonie D.
AU - Moss, Joanna F.
AU - Selicorni, Angelo
AU - Bisgaard, Anne-Marie
AU - Deardorff, Matthew A.
AU - Gillett, Peter M.
AU - Ishman, Stacey L.
AU - Kerr, Lynne M.
AU - Levin, Alex V.
AU - Mulder, Paul A.
AU - Ramos, Feliciano J.
AU - Wierzba, Jolanta
AU - Ajmone, Paola Francesca
AU - Axtell, David
AU - Blagowidow, Natalie
AU - Cereda, Anna
AU - Costantino, Antonella
AU - Cormier-Daire, Valerie
AU - FitzPatrick, David
AU - Grados, Marco
AU - Groves, Laura
AU - Guthrie, Whitney
AU - Huisman, Sylvia
AU - Kaiser, Frank J.
AU - Koekkoek, Gerritjan
AU - Levis, Mary
AU - Mariani, Milena
AU - McCleery, Joseph P.
AU - Menke, Leonie A.
AU - Metrena, Amy
AU - O'Connor, Julia
AU - Oliver, Chris
AU - Pie, Juan
AU - Piening, Sigrid
AU - Potter, Carol J.
AU - Quaglio, Ana L.
AU - Redeker, Egbert
AU - Richman, David
AU - Rigamonti, Claudia
AU - Shi, Angell
AU - Tumer, Zeynep
AU - Van Balkom, Ingrid D. C.
AU - Hennekam, Raoul C.
PY - 2018/10
Y1 - 2018/10
N2 - Cornelia de Lange syndrome (CdLS) is an archetypical genetic syndrome that is characterized by intellectual disability, well-defined facial features, upper limb anomalies and atypical growth, among numerous other signs and symptoms. It is caused by variants in any one of seven genes, all of which have a structural or regulatory function in the cohesin complex. Although recent advances in next-generation sequencing have improved molecular diagnostics, marked heterogeneity exists in clinical and molecular diagnostic approaches and care practices worldwide. Here, we outline a series of recommendations that document the consensus of a group of international experts on clinical diagnostic criteria, both for classic CdLS and non-classic CdLS phenotypes, molecular investigations, long-term management and care planning.
AB - Cornelia de Lange syndrome (CdLS) is an archetypical genetic syndrome that is characterized by intellectual disability, well-defined facial features, upper limb anomalies and atypical growth, among numerous other signs and symptoms. It is caused by variants in any one of seven genes, all of which have a structural or regulatory function in the cohesin complex. Although recent advances in next-generation sequencing have improved molecular diagnostics, marked heterogeneity exists in clinical and molecular diagnostic approaches and care practices worldwide. Here, we outline a series of recommendations that document the consensus of a group of international experts on clinical diagnostic criteria, both for classic CdLS and non-classic CdLS phenotypes, molecular investigations, long-term management and care planning.
KW - BRACHMANN-DELANGE-SYNDROME
KW - AUTISM SPECTRUM DISORDER
KW - OF-THE-LITERATURE
KW - GENOTYPE-PHENOTYPE CORRELATIONS
KW - SELF-INJURIOUS-BEHAVIOR
KW - DU-CHAT-SYNDROMES
KW - CONGENITAL DIAPHRAGMATIC-HERNIA
KW - AUTOSOMAL-DOMINANT INHERITANCE
KW - RUBINSTEIN-TAYBI SYNDROMES
KW - TO-MALE TRANSMISSION
U2 - 10.1038/s41576-018-0031-0
DO - 10.1038/s41576-018-0031-0
M3 - Review article
VL - 19
SP - 649
EP - 666
JO - Nature Reviews Genetics
JF - Nature Reviews Genetics
SN - 1471-0056
IS - 10
ER -